Bristol-Myers Squibb

Replying to @arkema_fp

The Born-Oppenheimer molecular dynamics captured the proton transfer event.

Replying to @balchem

Our structure-based design approach improved binding affinity by 100-fold.

Replying to @golden_pharma

Our co-factor regeneration system eliminated the need for expensive NADPH.

Replying to @akzonobel

Microphase separation in the triblock copolymer created well-defined gyroid morphology.

Replying to @archroma

The cell factory produced muconic acid at 85% of theoretical yield.

Replying to @merck_msd

The sintering temperature profile was optimized to achieve >98% theoretical density.

Replying to @zju_pharma

Wet bead milling to 200 nm improved the dissolution rate dramatically.

Replying to @galaxy

The filter compatibility study confirmed no adsorptive loss of the API.

Replying to @chem_impex

Good point. We should benchmark our methods against this approach.

Replying to @yyt

The sustainability angle is increasingly important for end customers.

Replying to @astel

Regulatory compliance in synthesis production is something we both take seriously.

Replying to @avantor2

Interesting position in the biotech market. Supply chain resilience is key going forward.